Hypolipidemic effect and activation of Lecithine Cholesterol Acyl Transferase (LCAT) by aqueous extract of  during toxicological investigation by unknown
RESEARCH ARTICLE Open Access
Hypolipidemic effect and activation of
Lecithine Cholesterol Acyl Transferase
(LCAT) by aqueous extract of Spirulina
platensis during toxicological investigation
Vicky Jocelyne Ama Moor1*, Prosper Cabral Nya Biapa2, Borgia Legrand Nono Njinkio3, Bruno Moukette Moukette1,
Zacharie Sando1, Cyril Kenfack4, Baruch Ateba4, Marthe Elise Ngo Matip5, Constant Anatole Pieme1
and Jeanne Ngogang1
Abstract
Background: Spirulina platensis produced in Nomayos (Cameroon) is used as a dietary supplement. S. platensis is
known as a neutraceutical with many beneficial effects on humans like lipid-lowering action. This study aims to
investigate the mechanism of hypolipidemic action of aqueous extract of Spirulina platensis (S. platensis) through
the toxicological studies.
Methods: In this study, we included two month old Wistar rats, weighing between 180 and 200 g. Aqueous S.
platensis was extracted and prepared using standard methods. The rats received a supplementation of S. platensis at
5000 mg/Kg of body weight as single dose in acute toxicity whereas different doses (250, 500, 1000 mg / kg body
weight) were administered in subacute toxicity compared to control. Acute and subacute toxicities were
determined according to the guidelines 420 (14 days) and 407 (28 days) of the Organization for Economic
Cooperation and Development (OECD) respectively. Biochemical parameters such as urea, creatinine, total and
direct bilirubin, lipid profile and transaminases; and histopathological analysis of the liver and kidneys were used to
evaluate the toxicity of S. platensis on these Wistar rats. Plasmatic hydroxymethyl glutaryl coenzyme A reductase
(HMG CoA reductase) and lecithine cholesterol acyl transferase (LCAT) were performed to explain the lipid-lowering
action of S. platensis. Histopathological analysis of the liver and kidneys was performed.
Results: Our results show a decrease in total cholesterol for male rats (from 84 to 74 mg/dl) when the dose of S.
platensis increased; this reduction of the total cholesterol level in male rats was significant at 500 mg/kg. There was
also a significant inhibition of HMG CoA reductase in a dose dependent manner between 25 and 84.5 fold
compared to the control in both male and female groups. At the dose of 250 mg/kg bw, the level of LCAT was
higher compared with other groups and control, but the difference was not statistically significant. A slight
inflammation in the liver and the mesangial hyperplasia of the renal glomeruli was revealed by the
histopathological investigation in subacute toxicity.
Conclusion: Spirulina platensis from Cameroon appears to have little toxic effects and may demonstrate
hypolipidemic activity through the activation of LCAT.
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Background
Spirulina is a cyanobacteria belonging to the class of
Cyanophyceae, Order of Oscillatoriaceae. It is also called
Arthrospira, with photosynthetic effects [1]. There are
several species of spirulina but the most consumed species
by men remains Spirulina platensis (S. platensis) also
called Arthrospira platensis. S. platensis naturally grows in
high-salt alkaline water reservoirs in subtropical and trop-
ical areas like America, Mexico, Asian and Central Africa
[2, 3]. S. platensis is a neutraceutical with many beneficial
effects on humans such as antiviral, immunomodulation,
immunostimulant, anti-inflammatory, hepatoprotective,
anti-cancer, antioxidant and lipid-lowering [4–8].
The hypolipidemic effect of S.platensis or its extracts
has been demonstrated in various animal models includ-
ing mouse, rat, hamster and rabbit [9]. The cholesterol
lowering activity of S. platensis was first reported in
albino rats [10], followed by mice [11].
Hyperlipidemia is the presence of high, or abnormal
levels of lipids and/or lipoproteins in the blood. There is
a correlation between coronary diseases and high levels
of lipoprotein [12].
Cardiovascular disease is a major cause of death in
developed countries and high cholesterol is an important
risk factor in atherosclerosis. Administration of S. platen-
sis to volunteer males demonstrated, that although there
was no significant increase in high- density lipoprotein
(HDL) levels, a significant reduction of Low-density lipo-
protein (LDL) cholesterol was noted after 8 weeks [13].
Other research describing the effects of S. platensis
supplements on patients with ischemic heart disease
found a significant reduction in blood cholesterol,
triglycerides and LDL cholesterol and an increase in
HDL cholesterol [14].
Recently in Cameroon, Ngo-Matip and al showed a
reduction of cholesterol and an increased HDL among
people living with HIV who consumed S. platensis [15].
Nevertheless, since dyslipidemias are a major cause of
atherosclerosis, drugs such as statins and even certain
herbs are used to lower cholesterol levels. The
cholesterol-lowering effect of statins is due to the
decrease in the biosynthesis of cholesterol by inhibition
of the enzyme 3-hydroxy-3-methylglutaryl coenzyme A
reductase (HMG CoA reductase). Some studies have
also reported the ex vivo inhibition of HMG CoA
reductase activity by herbs such as, Quercus infectoria,
Rosa damascene, Myrtus communis, Andrographis
paniculata, Anthocephalus indicus, and Ocimum
sanctum [16, 17].
Recently therapeutic upregulation of lecithine cholesterol
acyl transferase (LCAT) function has gained interest as a
potential new therapeutic strategy for reducing atheroscler-
osis. Strategies for therapeutically raising LCAT activity
include recombinant LCAT protein administration, viral
expression of LCAT, and small molecule activators of
LCAT [18].
Method
Preparation of aqueous extract of S. platensis
Spirulina platensis was produced and provided by an
NGO named CAP-Spiruline situated at Nomayos
(Yaounde- Cameroon).
Aqueous extract of S. platensis was obtained by macer-
ating 100 g of S. platensis powder with 1000 mL of dis-
tilled water. This mixture was then placed on intermittent
agitation for 24 h, and the filtrate obtained was immedi-
ately lyophilized. The powder obtained was used for
various studies. The extraction yield was 16.84% which
was calculated using the following formula: Rd =Mass of
the extract obtained × 100 / initial powder mass.
Animal and toxicity material
Before beginning the study, an ethical clearance was
obtained (N° 2016/01/699/CE/CNERSH/SP).
S. platensis was prepared by dissolving 500 mg of pow-
der in 1 ml of distilled water to obtain a stock solution
of 500 mg/ml.
Male and female Wistar rats around two months old
and between 180 and 200 g of weigh were used in this
study. They were all raised in physiological cage at the
Faculty of Medicine and Biomedical Sciences of the
University of Yaounde I. They had free access to water
and food. The food composition include: carbohydrates
(55%), proteins (20%), lipids (3.4%), cellulose (1%),
minerals (4.9%), vitamins (1.7%) and moisture (14%).
The acute toxicity was determined according to the
guideline 420 of the OECD [19]. A total of 20 rats
divided into 2 groups of 10 rats for each group (5 males
and 5 females) for the control and assay. The rats of the
control groups received distilled water while those of the
test group received a single dose (5000 mg/kg of body
weight) of S. platensis dissolved in distilled water. The
volume administered at each rat was calculated ac-
cording to the following formula: Volume (ml) = [dose
(mg/kg)* weight (kg)] / concentration (mg/ml).
For sub-acute, the guideline 407 was used [20]. In this
study, 40 rats were divided into 4 groups of 10 rats. A
group 1 called control received distilled water. The other
groups (2–4) received three different doses of S. platen-
sis (250, 500 and 1000 mg / kg body weight).
The extract of S. platensis was administered through
the orally by gavage using a needle once (acute toxicity)
and daily up to 28 days (sub-acute toxicity).
After 28 days, the rats were sacrificed after anesthesia
with ether; the blood was obtained by cervical disloca-
tion and collected in dry tubes for the determination of
biochemical parameters. These parameters included the
investigation of urea, total cholesterol, triglycerides, high
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density lipoprotein cholesterol levels using enzymatic and
colorimetric methods (CYPRESS, BELGIUM). The deter-
mination of creatinine concentration was carried out by
the kinetic Jaffe method (CYPRESS, BELGIUM) while the
activities of transaminases (AST and ALT) were performed
with kinetic method (CYPRESS BELGIUM).
The activity of hydroxy methyl glutaryl coenzyme A
reductase (HMG CoA reductase) was determined in the
plasma, by spectrophotometric method as described in
the kits (SIGMA ALDRICH, GERMANY). The assay is
based on a spectrophotometric measurement of the de-
crease in absorbance at 340 nm which represents the
oxydation of NADPH by the catalytic subunit of HMG
CoA reductase in the presence of the substrate HMG
CoA. The results are expressed as UI/mg of protein.
The lecithine cholesterol acyl transferase (LCAT)
activity was determined by a fluorimetric method using
a kit (SIGMA ALDRICH, GERMANY). The fluorescence
emission titration were recorded using an optic fiber
spectrometer Avantes 2048 (Avantes, Netherlands), with
spectral sensitivity within 250–1100 nm range. The
LCAT Activity Assay Kit is a fluorometric assay useful
for measuring the phospholipase activity of LCAT. We
have to mix 1 mL of LCAT Substrate Reagent with
200 mL of Assay Buffer and LCAT source (3–5 mL of
plasma or serum). Then to incubate for 4–8 h at 37 °C.
After what add 100 mL of the incubated mixture to
300 mL of Read Reagent and measure the fluorescent
label ( ex = 340/ em = 390 and 470 nm) and deter-
mine the plasmatic ratio ( em 470/ em 390).
Histopathology study
The sections of the liver and kidney were fixed in 10% buff-
ered formalin, dehydrated in ethanol, cleared in xylene, and
embedded in paraffin. Fixed tissues were sectioned using
a microtome. Then, these sections were stained with
hematoxylin and eosin and were examined under the
optic microscope for toxicant induced changes.
Statistical analysis
Results are expressed as Mean ± SD of triplicate assays.
The factor has been tested using Kruskal wallis test and
Dunnett’s and Bonforroni multiple test helped for
establishing difference between means. Ponderal growth
as well as LCAT activity between male and female at
each concentration were analyzed through independent
sample T-test. The relationship between parameters was
achieved with the Spearman rho Correlation Ana-
lysis. The differences were considered as significant
at P < 0.05. SPSS hardware, version 18.0 for Windows
helped in analyzing data.
Results
Physical observations indicated no signs of changes in
the skin, fur, eyes mucous membrane, behaviour pat-
terns, tremors, salivation, and diarrhoea of the rats.
There was neither mortality observed at the tested dose
nor weight loss in the rats receiving S. platensis. The
fifty percent lethal dose (LD50) of S. Platensis extract
was therefore estimated to be more than 5000 mg/kg.
We noted a significant (p <0.05) weight gain in male rats
ingesting S. platensis compared to the control male
group (Table 1). This difference was not significant in
the group of female rats.
The Table 2 shows the results of lipid profile during
subacute toxicity. The level of total cholesterol decreased
in the male groups of rats treated with S. platensis com-
pare with control; this reduction was only statistically
significant at 500 mg/kg. Regarding the level of HDL
cholesterol, only the female group exhibited a significant
decrease of concentration mainly at 1000 mg/kg.
The effects of subacute administration of S. platensis ex-
tract on liver and kidney biochemical parameters are pre-
sented in Table 3. Most of these biochemical assays in
treated rats were not significantly different from the controls,
with the exception of albumin which was low at 500 mg/kg.
Table 4 shows the variations of HMG CoA reductase
activity in both groups of rats. In both male and female
rats, we found inhibition of the enzyme in rats fed by S.
platensis; this inhibition is dose-dependent, marked with
a dose of 1000 mg/kg. The difference between the
groups is statistically significant (p < 0.05).
The variation in LCAT activity of the rats presented in
the Fig. 1 shows that at the dose of 250 mg/kg bw, the
level of LCAT was higher both in male and female
Table 1 Weight of the groups of rats
Days Weight of rats (Mean ± SD)
Control female Test female Control male Test Male
Day 1 117,60 ± 10,784 118,6 ± 16,622 117 ± 14,832 117,8 ± 10,426
Day 7 138,40 ± 11,194 146,00 ± 20,261 149,20 ± 16,814 161,60 ± 9,503
Day 14 144,00 ± 8,031 155,60 ± 19,476 167,20 ± 17,669 193,20 ± 13,424
Mean weight gained
between day 1 and day 14
26.4 ± 15.59 37 ± 28.50 50.2 ± 22.12 75.4 ± 20.25
p value p > 0.05 p <0.05
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groups compared to control. However, this variation was
not statistically significant within the groups (p = 0.399
for males groups and p = 0.801 for females groups).
When comparing the sex, the level of LCAT was signifi-
cantly higher in males compared to female except at
250 mg/kg [p = 0.02 (control); p = 0.07 (250 mg/kg body
weight); p = 0.003 (500 mg/kg body weight); p = 0.04
(1000 mg/kg body weight)].
Figure 2 shows the histopathological studies of livers
and kidneys of the rats fed with S. platensis. We found
the presence of an inflammatory granuloma especially at
the doses 500 or 1000 mg/kg bw. This inflammation is
the evidence of lymphocyte multiplication and is not
accompanied by cytolysis. The kidney sections show
chronic interstitial inflammatory infiltrate microfoci pre-
dominant around the tubules with mesangial hyperplasia
especially at 250 mg / kg the female rats in particularly.
However, at the highest dose, the histopathology of the
kidneys is normal.
Discussion
Various herbs have been used as treatment and preven-
tion for several chronic diseases such as diabetes, hyper-
cholesterolemia and triglyceridemia. In screening natural
products for the pharmacological activity, assessment
and evaluation of the toxic characteristics of a natural
product extract, fraction, or compound are usually an
initial step. In our study we investigated the effects of
aqueous extract of S. platensis on lipid profile mainly on
the plasmatic activity of LCAT and HMG-CoA reductase
after 28 days of toxicological studies.
Acute toxicity is defined as adverse effects occurring
because of short-term administration of a single dose or
multiple doses given within 24 h [21]. Acute toxicity
tests give a quantitative estimation of acute toxicity,
identify target organs and other clinical manifestations
of acute toxicity and provide guidance for dose-ranging
studies. This test is usually a valid predictor of the
response seen in humans [18]. Indeed, the literature
reports that the substances with LD50 higher than 5 g/kg
b.w., by oral route are regarded as being safe or practic-
ally non-toxic [22]. This is an indication that the
aqueous solution of S. platensis has negligible level of
toxicity when administered orally. At a dose of 5000 mg/
kg, S. platensis showed no deaths of rats after acute
toxicity. Also, the LD (lethal dose) value for phycocyanin
a main active component of S. platensis extract has been
higher than 5000 mg/kg [23].
Furthermore, the diets and water were well-accepted
by the rats treated with S. platensis extract suggesting
the extract did not cause any alterations in carbohydrate,
protein or fat metabolism in these experimental animals.
Our results also showed that the S. platensis extract did
not adversely interfere with the nutritional benefits, such
as weight gain and stability of the appetite. The body




















Control 66 ± 23 42 ± 7a 250 ± 118 1.64 ± 0.42 92 ± 17a 52 ± 6 385 ± 90 1.76 ± 0.14
250 62 ± 12 43 ± 8a 257 ± 98 1.44 ± 0.19 84 ± 9a 53 ± 9 294 ± 147 1.58 ± 0.17
500 61 ± 11 40 ± 8a 207 ± 160 1.50 ± 0.10 74 ± 6b 40 ± 3 229 ± 152 1.85 ± 0.32
1000 57 ± 4 35 ± 5b 289 ± 127 1.62 ± 0.19 89 ± 14a 49 ± 3 334 ± 86 1.81 ± 0.19
In the same column, the values subscripted with the same letter are not significantly different at p < 0.05
Bw body weight, TC total cholesterol, HDL C High Density Lipoprotein cholesterol, LDL C Low Density Lipoprotein cholesterol, TG Triglycerides

















Females Control 34.75 ± 1.29 0.59 ± 0.06 9.94 ± 1.33 295.93 ± 32.85 64.11 ± 7.23 1.23 ± 0.48 0.43 ± 0.31
250 35.65 ± 1.41 0.53 ± 0.05 9.04 ± 0.57 324.05 ± 78.35 71.71 ± 20.47 1.34 ± 0.36 0.39 ± 0.19
500 33.9 33.98 ± 2.63 0.62 ± 0.12 8.65 ± 1.59 288.70 ± 58.60 68.54 ± 23.08 0.95 ± 0.22 0.32 ± 0.14
1000 35.01 ± 0.75 0.53 ± 0.10 9.96 ± 1.08 379.43 ± 126.9 77.17 ± 19.96 1.48 ± 0.26 0.55 ± 0.07
Males Control 34.23 ± 0.94a 0.62 ± 0.24 8.97 ± 1.75 344.75 ± 136.46 91.58 ± 37.29 1.07 ± 0.20 0.42 ± 0.19
250 36.31 ± 0.82ab 0.56 ± 0.21 9.30 ± 0.76 337.78 ± 125.44 80.32 ± 18.59 1.26 ± 0.38 0.52 ± 0.42
500 31.07 ± 2.42c 0.62 ± 0.14 9.24 ± 0.67 291.90 ± 22.72 112.39 ± 33.07 1.14 ± 0.41 0.51 ± 0.19
1000 34.58 ± 0.62a 0.61 ± 0.07 9.02 ± 0.33 357.86 ± 75.02 102.29 ± 16.56 1.25 ± 0.26 0.46 ± 0.15
In the same column, the values subscripted with the same letter are not significantly different at p < 0.05
Bw body weight, AST Aspartate Amino transferase, ALT Alanine Amino Transferase, T Bili total bilirubin, D Bili direct bilirubin, Alb albumin
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weight changes serve as a sensitive indication of the
general health status of animals [24].
Subchronic toxicity studies on S. platensis have been
conducted by some researchers [21]. Our toxicological
study brings some differences, mainly in the feeds given
to the animals, the time of administration, and the kind
of analysis conducted. The exploration of liver and
kidney function is very important in the investigation of
toxicity of drugs and plant extracts as they are both
necessary for the survival of an organism [25]. High
levels of ALT, AST, and alkaline phosphatase (ALP) are
reported in liver diseases or hepatotoxicity [26]. No
significant changes was found in ALT, AST, in our study
in both male and female rats at all doses suggesting that
the administration of S. platensis extract does not affect
the hepatocyte function in the rats. In a chemopreven-
tive study of S. platensis against deltamethrin, Abdel--
Daim and al [27] observed a reduction of hepatic
markers (transaminases, alkaline phosphatase, bilirubin,
total cholesterol) and renal markers (urea, creatinine,
uric acid). The liver sections revealed significant
lymphocytic multiplication. Previous studies showed the
hepatoprotective effects of S. platensis and its active
constituents against drugs, chemicals and xenobiotics
[28–30].
The protective role of S. platensis could be attributed
to the presence of ß-carotene, superoxide dismutase, sel-
enium and blue pigment phycocyanin in the algae [5].
Phycocyanin significantly reduced the hepatotoxicity
caused by paracetamol which induces the formation of
free radicals. The hepatoprotective effect of phycocyanin
was therefore attributed to the inhibition of reaction
involved in the formation of reactive metabolites and
possibly due to its radical scavenging activity. Also, a
study has revealed that the hepatoprotective mechanism
of S. platensis passes through the presence of phyco-
cyanin and is related to the blockage of inflammatory
infiltration by inhibiting the expression of tumor growth
factor-beta 1 and hepatocyte growth factor [31, 32].
Our study demonstrated no changes in plasma urea and
creatinine levels in S. platensis extract treated groups indi-
cating a normal renal function. The nephroprotective
effects of S. platensis have been reported against renal
injury induced by gentamicin [33] as well as oxalate [34].
The effective compound responsible for the suppression
of renal toxicity seems to be phycocyanin [35].
Changes in the parameters of the lipid profile between
different groups of rats were not significant, except for
cholesterol.
Cholesterol reduction and related effects of S. platensis
have been reported mostly in subjects with elevated
blood lipid levels [36]. It has been shown that adminis-
tration of Arthrospira maxima (specie of Spirulina)
associated with simvastatin prevents the acute fatty liver
Table 4 Activity of HMG CoA reductase of males and females
rats after 28 days administration of Spirulina platensis
Groups HMG CoA reductase activity (UI/mg protein)
Rats Males Rats Females
control 0.38 ± 0.001a 13.45 ± 0.002a
250 mg/kg 0.13 ± 0.002b 3.99 ± 0.000b
500 mg/kg 0.06 ± 0.000c 5.07 ± 0.007c
1000 mg/kg 0.02 ± 0.000d 0.50 ± 0.000d
In the same column, the values subscripted with the same letter are not
significantly different at p < 0.05
Fig. 1 Variation of LCAT activity of male and female rats after 28 days administration of Spirulina platensis. The values subscripted with the same
letter are not significantly different at p < 0.05
Ama Moor et al. BMC Nutrition  (2017) 3:25 Page 5 of 8
induced by the administration of ethanol and a hyper-
cholesterolemic diet to mice [37].
The hypocholesterolemic effects of Arthrospira
maxima are in accordance with other reports on rats
when it was given in a normal diet [38] with a high-
fructose diet [39] or when Arthrospira maxima was
administered to humans, 4.2 g / day during 4 weeks
[13]. Hyperlipidemia lowering effect of S. platensis seems
to be more sensitive in an experimental model than in a
normal blood lipid range [40].
The cholesterol homeostasis is very important for the
human health. HMG COA reductase is the rate-limiting
step in the biosynthesis of cholesterol in humans: it
converts HMG COA into mevalonate. The inhibition of
this enzyme would be an effective means of lowering
plasma cholesterol. It has been suggested that exogenous
cholesterol inhibits the expression of mRNA for of 3-
hydroxy-3-methyl coenzyme A reductase (HMG CoA
reductase) [39, 41] that appears after the intracellular
mevalonate deficit in the liver. The inhibition of HMG
CoA reductase produces a depletion of the mevalonate
metabolites which is critical for cellular viability [24, 42].
Regulation of HMG CoA reductase activity is the
primary approach for controlling de novo cholesterol
synthesis, while abnormal activation can lead to hepatic
cholesterol accumulation and hypercholesterolemia. Full
suppression of the reductase requires the presence of at
least two regulators: cholesterol, which is normally
derived exogenously from plasma low density lipopro-
tein (LDL), and a non-sterol product, which is normally
synthesized endogenously from mevalonate [16]. The
major metabolic pathway for reducing cholesterol is via
conversion to bile acids or preventing the cholesterol
synthesis by inhibiting the HMG CoA reductase enzyme.
In our study, we found that the decrease of plasmatic
HMG COA reductase in the plasma of the treated group
was between 2.9 and 26.9 fold higher compared to con-
trol. Moreover, the ratio between HMG CoA reductase
of the female and male rats varied from 25 to 84.5 with
the maximum at the dose of 250 mg/kg bw. These
results confirmed that the administration of S. platensis
inhibits the plasmatic activity of HMG COA reductase
significantly in the male than the female rats. The
enzyme inhibitory effect correlates with the medicinal
properties and phytochemical components of S. platensis
such as phenol and flavonoids compounds. Some studies
have also reported the ex vivo inhibition of HMG CoA
reductase activity by herbs specially medicinal plants,
namely, Quercus infectoria, Rosa damascene, Myrtus
communis, Andrographis paniculata, Anthocephalus
indicus, and Ocimum sanctum [16, 17]. Clinical trials
have shown that the use of HMG CoA reductase inhibi-
tors in patients with coronary risk improved endothelial
function through reduction of oxidative stress and/or up
regulation of NO activity [43].
Lecithin cholesterol acyltransferase (LCAT) is one of
the major modulators of plasma high-density lipoprotein
cholesterol (HDL-C) and plays a central role in the
reverse cholesterol transport (RCT) process [44]. LCAT
is a plasma enzyme that circulates mostly in association
with the high density lipoproteins (HDL) and is respon-
sible for the synthesis of cholesterol esters present in
human plasma. Cholesterol esterification catalyzed by
LCAT also reduces the amount of unesterified choles-
terol in plasma. The level the highest level of LCAT was
noted at 250 mg/kg bw demonstrating the increase of
esterification of cholesterol which lead to the synthesis
of HDL-C. These findings corroborate with the higher
concentration of HDL-C noted in the group of rats
receiving 250 mg/kg of S. platensis extract. Therefore
LCAT plays a key role in the incorporation of free
cholesterol into HDL and its transfer back to VLDL
and LDL, which are later returned in liver cells [45].
Our study has shown that the synergistic effect of
HMG CoA reductase inhibition and LCAT activation
reduced the level of cholesterol in the group of rats





Fig. 2 Histopathology of the liver; hematoxylin and eosin X40. (a)
control (b) 250 mg/kg bw (c) 500 mg/kg bw (d) 1000 mg/kg bw. (b)
Histopathology of the kidney; hematoxylin and eosin X10. (e) control
(f) 250 mg/kg bw (g) 500 mg/kg bw (h) 1000 mg/kg bw
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Conclusions
Administration of aqueous extract of S. platensis from
Nomayos in Cameroon resulted in little toxic effects. It
demonstrates hypolipidemic activity through an activa-
tion of LCAT. The findings provide preliminary data
that suggest that S. platensis is capable of reducing total
cholesterol. Further studies are needed to confirm this
result by inducing hypercholesteromia.
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